Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Immunology"

134 News Found

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
News | May 09, 2022

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA

Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets


Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business
People | May 09, 2022

Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business

He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation


Lupin Diagnostics launches reference laboratory in Guwahati, Assam
Diagnostic Center | April 29, 2022

Lupin Diagnostics launches reference laboratory in Guwahati, Assam

It is expanding the diagnostics business footprint in North East India


Sanofi continues to deliver strong business
News | April 28, 2022

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate


Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours
Biotech | April 25, 2022

Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours

Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Biotech | April 13, 2022

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases


Novel Covid-19 vaccine may protect the immunocompromised
Biotech | April 13, 2022

Novel Covid-19 vaccine may protect the immunocompromised

The peptide-based vaccine induces a t cell-dependent response


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
Biotech | April 07, 2022

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format